Pallas Capital Advisors LLC Sells 85 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pallas Capital Advisors LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,069 shares of the healthcare conglomerate’s stock after selling 85 shares during the quarter. Pallas Capital Advisors LLC’s holdings in UnitedHealth Group were worth $10,152,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Hanson & Doremus Investment Management boosted its position in shares of UnitedHealth Group by 10.9% in the second quarter. Hanson & Doremus Investment Management now owns 459 shares of the healthcare conglomerate’s stock valued at $234,000 after acquiring an additional 45 shares during the period. Retirement Planning Co of New England Inc. increased its holdings in shares of UnitedHealth Group by 5.4% during the 2nd quarter. Retirement Planning Co of New England Inc. now owns 448 shares of the healthcare conglomerate’s stock worth $228,000 after purchasing an additional 23 shares during the period. WINTON GROUP Ltd bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $228,000. Fairfield Financial Advisors LTD bought a new position in UnitedHealth Group during the second quarter valued at about $2,194,000. Finally, Capital Wealth Planning LLC lifted its position in shares of UnitedHealth Group by 4.1% in the 2nd quarter. Capital Wealth Planning LLC now owns 1,016,952 shares of the healthcare conglomerate’s stock worth $517,893,000 after acquiring an additional 39,713 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 4.0 %

UNH stock opened at $541.28 on Tuesday. The business has a fifty day moving average of $554.92 and a 200-day moving average of $562.88. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $498.13 billion, a P/E ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the company earned $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, Cantor Fitzgerald lifted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.